Comparison of N-Terminal Pro-Brain Natriuretic Peptide Versus Electrophysiologic Study for Predicting Future Outcomes in Patients With an Implantable Cardioverter Defibrillator After Myocardial Infarction
- 15 August 2007
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 100 (4), 635-639
- https://doi.org/10.1016/j.amjcard.2007.03.074
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapiesHeart, 2006
- N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure PatientsCirculation, 2004
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJournal of the American College of Cardiology, 2002
- B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart FailureCirculation, 2002
- Hospital readmission after transvenous cardioverter/defibrillator implantation. A single centre studyEuropean Heart Journal, 2000
- Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden DeathNew England Journal of Medicine, 2000
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular ArrhythmiaNew England Journal of Medicine, 1996
- What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?Circulation, 1991
- Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidneyNature, 1986